Join to View Full Profile
2002 Holcombe BlvdHouston, TX 77030
Phone+1 713-791-1414
Dr. Chen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Baylor College of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 2015 - 2017- Baylor College of MedicineResidency, Internal Medicine, 2012 - 2015
Indiana University School of MedicineClass of 2012
Certifications & Licensure
TX State Medical License 2017 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
- A Study of PCSK9 Inhibitor AK102 in Healthy Subjects Start of enrollment: 2018 May 23
- A Clinical Study of AK101 in Subjects With Moderate to Severe Plaque Psoriasis Start of enrollment: 2018 Jan 09
Publications & Presentations
PubMed
- PRDM16 Enhances Osteoblastogenic RUNX2 via Canonical WNT10b/β-CATENIN Pathway in Testosterone-Treated Hypogonadal Men.Siresha Bathina, Mia Prado, Virginia Fuenmayor Lopez, Georgia Colleluori, Lina Aguirre
Biomolecules. 2025-01-08 - Health implications of racial differences in serum growth differentiation factor levels among men with obesity.Siresha Bathina, Virginia Fuenmayor Lopez, Mia Prado, Elliot Ballato, Georgia Colleluori
Physiological Reports. 2024-12-01 - A multifunctional evanescent wave biosensor for the universal assay of SARS-CoV-2 variants and affinity analysis of coronavirus spike protein-hACE2 interactions.Bo Jiang, Yi Yang, Rongtao Zhao, Dan Chen, Yule Wang
Biosensors & Bioelectronics. 2024-09-15
Journal Articles
- Microfluidic Cell Deformability Assay for Rapid and Efficient Kinase Screening with the CRISPR‐Cas9 SystemRui Chen, Xin Han, Angewandte Chemie
Press Mentions
NT/ Nanoparticles Create Heat from Light to Manipulate Electrical Activity in NeuronsJuly 26th, 2021
A Genome-Scale CRISPR Cas9 Dropout Screen Identifies Synthetically Lethal Targets in SRC-3 Inhibited Cancer CellsMarch 25th, 2021- Vizgen Debuts Next Generation Genomics Platform at AGBTMarch 1st, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
